Role of Artificial Intelligence in Oncology
About Role of Artificial Intelligence in Oncology
Artificial intelligence can analyse scans, pathology slides, genetic data and health records faster than people and spot patterns that are easy to miss. In oncology, AI is helping detect cancer earlier, predict outcomes and support treatment decisions.
The Role of Artificial Intelligence in Oncology session at Cancer Research 2027 covers AI from research to clinical use. It connects closely with cancer imaging techniques, one of the areas where AI is most advanced.
AI tools learn from large collections of images, records and test results. In cancer care, they can flag suspicious areas on scans, grade tumours on pathology slides and predict how a patient may respond to treatment. These tools are designed to support doctors, not replace them. Careful testing is needed to make sure they are accurate and fair for all patients.
Key Topics in Role of Artificial Intelligence in Oncology
• AI in cancer screening and early detection
• Deep learning for radiology
• Digital and computational pathology
• AI for genomic and molecular data
• Outcome and survival prediction
• AI in radiotherapy planning
• Clinical decision support in oncology
• Large language models in cancer care
• Bias, safety and validation
• Regulation and deployment of AI tools
Recent Advances in Role of Artificial Intelligence in Oncology
AI tools are now approved to help read mammograms and detect lung nodules, and digital pathology systems are supporting tumour grading. These tools support cancer detection and diagnosis by reducing missed cancers and speeding up results.
AI is also speeding up radiotherapy planning and predicting which patients will respond to treatment, linking with precision oncology. Using patient data responsibly is a key concern explored in ethical considerations in cancer research and clinical trials.
Several AI tools for breast screening, lung nodule detection and pathology are now approved for use. Researchers are combining imaging, genetic and clinical data to make more complete predictions. Hospitals are learning how to fit these tools into daily work safely. Attention is also growing on bias, transparency and how patients feel about AI in their care.
Who Should Attend the Role of Artificial Intelligence in Oncology Session
• Oncologists, radiologists and pathologists
• AI and data science researchers
• Medical physicists
• Health IT and digital health teams
• PhD students and early-career researchers
• Oncology technology companies
Why Present Your Research in Role of Artificial Intelligence in Oncology
Presenting at Cancer Research 2027 lets you share AI research with oncologists who can test it in practice. You can connect with colleagues in clinical research and clinical trials of cancer using AI to design better studies. Clinicians and data scientists both attend, giving you feedback from every side. This is a valuable chance to find partners for testing your tools in real settings.
Frequently Asked Questions
Do I need clinical validation to submit an AI study?
No. Early-stage models are welcome, though validation results are encouraged.
Does this session cover digital pathology?
Yes. Digital and computational pathology are key topics.
Where is Cancer Research 2027?
Cancer Research 2027 is held at Village Hotel Changi, Singapore, from 8 to 10 March 2027, with online participation.